UNESCO Chair in Bioethics 12th World Conference Bioethics ...
Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National...
-
Upload
doreen-mclaughlin -
Category
Documents
-
view
216 -
download
0
Transcript of Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National...
![Page 1: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/1.jpg)
Providing Research Results to Participants
David ShalowitzDepartment of Clinical Bioethics
National Institutes of Health
Pre-conference Program: Pre-conference Program: Advanced Research EthicsAdvanced Research EthicsOctober 28, 2004October 28, 2004
![Page 2: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/2.jpg)
Definition
ResultsResults: Data collected about a given : Data collected about a given
participant during the course of participant during the course of research—i.e. research—i.e. individualizedindividualized results. results.
![Page 3: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/3.jpg)
Case #1
Investigators discover that two siblings have a gene preliminarily associated with a disease that may cause loss of visual acuity or blindness. If pathology is identified early, vision loss can be prevented.
Should investigators inform the siblings of the findings?
Does it depend on the type of study?
![Page 4: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/4.jpg)
Case #2
Investigators are conducting a large epidemiological study to determine whether various factors (social, economic, genetic) are associated with a greater risk for the development of heart disease.
Should the investigators notify participants of potential risk factors at the conclusion of the study?
What if a participant requests his or her results?
![Page 5: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/5.jpg)
Disclaimer
The views expressed in this presentation The views expressed in this presentation do not represent the official policies of do not represent the official policies of the NIH, DHHS or the USPHS.the NIH, DHHS or the USPHS.
![Page 6: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/6.jpg)
What are researchers’ responsibilities to participants?
Pure Clinical Model
Act to maximize the health of the participant
Pure Research Model
Act solely to collect generalizable data
![Page 7: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/7.jpg)
Why the pure clinical model fails:
Researchers seek to create generalizable knowledge, not to maximize the health of participants
Research interventions are determined by protocol, not by characteristics of individual participants
Example: Randomized Controlled Trials
![Page 8: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/8.jpg)
What are researchers’ responsibilities to participants?
Pure Clinical Model
Act to maximize the health of the participant
Pure Research Model
Act solely to collect generalizable dataX
![Page 9: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/9.jpg)
Why the pure research model fails:
The “pure research” model would imply that investigators are free to collect information from participants without any regard for their needs and interests.
Implication for information of imminent heart attack?
This is implausible.
![Page 10: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/10.jpg)
What are researchers’ responsibilities to participants?
Pure Clinical Model
Act to maximize the health of the participant
Pure Research Model
Act solely to collect generalizable dataX X
![Page 11: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/11.jpg)
What are researchers’ responsibilities to participants?
The “pure clinical” model fails, as does the “pure research” model.
Where do we go from here?
![Page 12: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/12.jpg)
Collaborative partnership Social value Scientific validity Fair subject selection Favorable risk/benefit ratio Independent review Informed consent Respect for participants
8 principles of ethical clinical research
![Page 13: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/13.jpg)
What does “respect” require of investigators?
Investigators should communicate individualized results to participants that are meaningful.
![Page 14: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/14.jpg)
What constitutes meaningful information?
Is the information likely to be clinically relevant? Are there implications for further screening, treatment or
prevention?
…relevant to reproductive decisions? E.g. Gene carrier status
…relevant to life-planning? E.g. Early- or late-onset conditions without possible
intervention
…desired by participants for other cultural or social reasons? E.g. Information about ancestry
![Page 15: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/15.jpg)
Respect and requests
Respect for participants also confers a responsibility on investigators to respond to requests for results.
![Page 16: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/16.jpg)
NIH Human Subjects Research Advisory Committee (1998)
Participants may access research information unless:
1. Information would compromise a promise of confidentiality
2. Information may endanger the life or physical safety of an individual
3. Access would compromise the scientific validity of the study (e.g. blinding) OR
4. Information has not been established to have clinical utility or validity at the time of review
![Page 17: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/17.jpg)
Participant access to information of uncertain significance Potential Concerns:
Risk of misinformation Misinterpretation of information Cost of disclosure
These concerns can and should be addressed, but they do not appear to be overriding reasons to withhold results.
![Page 18: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/18.jpg)
Exceptions to disclosure
Information would compromise a promise of confidentiality
Information may endanger the life or physical safety of an individual
Access would compromise the scientific validity of the study (e.g. blinding) OR
Expected costs of access would make the study prohibitively expensive to conduct.
If requested, study results should be disclosed to participants unless:
*
![Page 19: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/19.jpg)
Method of Disclosure
Meaningful information should be disclosed in a manner that has meaning for participants. “Plain Language” requirements, etc. Disclosure to third-parties when necessary. Results should be offered.
Similarly, when results are requested by participants, investigators should try to address the participants’ underlying concerns.
![Page 20: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/20.jpg)
Investigators discover that two siblings have a gene preliminarily associated with a disease that may cause loss of visual acuity or blindness. If pathology is identified early, vision loss can be prevented.
Should investigators inform the siblings of the findings?
Does it depend on the type of study?
Case #1 Revisited
Yes—this result appears to be clinically meaningful
Probably not—the information itself is enough to warrant disclosure
![Page 21: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/21.jpg)
Case #2 Revisited
Investigators are conducting a large epidemiological study to determine whether various factors (social, economic, genetic) are associated with a greater risk for the development of heart disease.
Should the investigators notify participants of potential risk factors at the conclusion of the study?
What if a participant requests his or her results?
Investigators should disclose the results, but should ensure that the request is not based on a misunderstanding
Probably not—these data are unlikely to be meaningful
![Page 22: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/22.jpg)
Application
What text should be included in protocols and consent forms?
![Page 23: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/23.jpg)
Possible boilerplate text for informed consent
The researchers will offer you the results of tests that they judge to be meaningful to you, including results that may be useful for your health care.
If there is some information that you do NOT want to know about yourself, please tell us, or call Dr. _______ at ______.
Also, if you would like the results of a specific test conducted during this study, please tell us, or call Dr. _______ at _______.
(Grade level 9.3)
![Page 24: Providing Research Results to Participants David Shalowitz Department of Clinical Bioethics National Institutes of Health Pre-conference Program: Advanced.](https://reader036.fdocuments.us/reader036/viewer/2022062409/56649eef5503460f94bff081/html5/thumbnails/24.jpg)
Conclusions
Investigators have a responsibility to offer meaningful results to participants. I.e., information relevant to health, reproduction, life plans,
culture or information specifically requested by participant
Information should be communicated in a manner that is responsive to participants’ needs and interests Information is made understandable or disclosed to a third
party Information is offered, not automatically disclosed
Investigators should develop plans for dealing with results during study design, with the help of the IRB.